Technical Analysis for EPRX - Eupraxia Pharmaceuticals Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 3.10 | 24.00% | 0.60 |
EPRX closed up 24.0 percent on Friday, November 1, 2024, on 21.52 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. The bulls were able to push the stock to a new 52-week high.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 50 DMA | Bullish | 0.00% | |
| MACD Bullish Centerline Cross | Bullish | 0.00% | |
| New 52 Week Closing High | Bullish | 0.00% | |
| Expansion Breakout | Bullish Swing Setup | 0.00% | |
| Expansion Pivot Buy Setup | Bullish Swing Setup | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% | |
| New 52 Week High | Strength | 0.00% | |
| Above Upper BB | Strength | 0.00% |
| Alert | Time |
|---|---|
| New 52 Week High | about 21 hours ago |
| Up 2 ATRs | about 21 hours ago |
| Up 10% | about 21 hours ago |
| 10 DMA Support | 1 day ago |
| 50 DMA Support | 1 day ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/09/2024
Eupraxia Pharmaceuticals, Inc. operates as a drug delivery technology company in Canada. It delivers drugs into body compartments, such as the joint without any of the common issues with body compartment injections, such as systemic exposure. The firm focuses on arthritis, diabetic macular edema, and chronic pain programs. The company was founded by James A. Helliwell and John Salvatore Montalbano on May 12, 2011 and is headquartered in Victoria, Canada.
Sector: Healthcare
Industry: Biotechnology
Keywords: Chronic Pain Chronic Condition Diabetic Retinopathy Macular Edema Arthritis Diabetic Macular Edema Drug Delivery Technology Medical Signs
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Chronic Pain Chronic Condition Diabetic Retinopathy Macular Edema Arthritis Diabetic Macular Edema Drug Delivery Technology Medical Signs
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.79 |
| 52 Week Low | 2.215 |
| Average Volume | 9,652 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 2.57 |
| 20-Day Moving Average | 2.49 |
| 10-Day Moving Average | 2.55 |
| Average True Range | 0.27 |
| RSI (14) | 69.79 |
| ADX | 16.95 |
| +DI | 50.98 |
| -DI | 10.56 |
| Chandelier Exit (Long, 3 ATRs) | 2.98 |
| Chandelier Exit (Short, 3 ATRs) | 3.03 |
| Upper Bollinger Bands | 2.82 |
| Lower Bollinger Band | 2.15 |
| Percent B (%b) | 1.43 |
| BandWidth | 26.62 |
| MACD Line | 0.03 |
| MACD Signal Line | -0.02 |
| MACD Histogram | 0.0503 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.04 | ||||
| Resistance 3 (R3) | 5.05 | 4.42 | 4.71 | ||
| Resistance 2 (R2) | 4.42 | 3.93 | 4.41 | 4.60 | |
| Resistance 1 (R1) | 3.76 | 3.62 | 4.09 | 3.75 | 4.50 |
| Pivot Point | 3.13 | 3.13 | 3.30 | 3.12 | 3.13 |
| Support 1 (S1) | 2.47 | 2.64 | 2.80 | 2.46 | 1.70 |
| Support 2 (S2) | 1.84 | 2.33 | 1.83 | 1.60 | |
| Support 3 (S3) | 1.18 | 1.84 | 1.49 | ||
| Support 4 (S4) | 1.17 |
